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Abstract
Background: Phosphoinositide 3-kinases (PI3Ks) regulate numerous physiological processes including some aspects of
cardiac function. Although regulation of cardiac contraction by individual PI3K isoforms has been studied, little is known
about the cardiac consequences of downregulating multiple PI3Ks concurrently.
Methods and Results: Genetic ablation of both p110a and p110b in cardiac myocytes throughout development or in adult
mice caused heart failure and death. Ventricular myocytes from double knockout animals showed transverse tubule (T-
tubule) loss and disorganization, misalignment of L-type Ca
2+ channels in the T-tubules with ryanodine receptors in the
sarcoplasmic reticulum, and reduced Ca
2+ transients and contractility. Junctophilin-2, which is thought to tether T-tubules
to the sarcoplasmic reticulum, was mislocalized in the double PI3K-null myocytes without a change in expression level.
Conclusions: PI3K p110a and p110b are required to maintain the organized network of T-tubules that is vital for efficient
Ca
2+-induced Ca
2+ release and ventricular contraction. PI3Ks maintain T-tubule organization by regulating junctophilin-2
localization. These results could have important medical implications because several PI3K inhibitors that target both
isoforms are being used to treat cancer patients in clinical trials.
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Introduction
Efficient cardiac mechanical function depends on tight coupling
between the electrically excitable myocyte surface membrane and
intracellular Ca
2+ stores in the sarcoplasmic reticulum (SR) [1]. In
mature mammalian ventricular myocytes, rapid and synchronous
Ca
2+ release throughout the cell in response to an action potential is
made possible by a densenetwork of plasmamembrane invaginations
called transverse tubules (T-tubules) [2]. The surface membrane
invaginations form near the sarcomere Z lines at regular ,2 mm
intervals along the longitudinal axis of the myocyte.




2+-handling proteins are concentrated in these
junctionalmembranecomplexes(dyadjunctions).Voltage-dependent
L-type Ca
2+ channels (CaV1.2) are located in the T-tubules, and the
jSR membrane contains ryanodine receptor 2 (RyR) Ca
2+ release
channels. Propagation of the action potential into the cell interior via
the T-tubules activates a relatively small inward Ca
2+ current (ICa,L)
through CaV1.2. This Ca
2+ rapidly diffuses across the narrow dyadic
cleft to induce a much larger release of Ca
2+ from the SR through
RyR, leading to myocyte contraction. The density of T-tubules, their
juxtaposition to the jSR, and proper localization to the contractile
machinery are necessary for efficient Ca
2+-induced Ca
2+ release and
synchronized contraction in ventricular myocytes [4,5].
T-tubules in mammalian ventricular myocytes develop after
birth [6] and can undergo remodeling or loss in heart disease
[4,7–10]. Although the exact mechanisms that control T-tubule
formation and maintenance are unknown, junctophilin-2 (JP-2)
has been implicated in regulating this cellular structure. The four
members of the junctophilin family are believed to tether the
plasma membrane to the SR/endoplasmic reticulum in excitable
cells [11,12]. JP-2, the major junctophilin isoform expressed in the
heart, has a transmembrane domain at the carboxyl terminus that
anchors the protein in the SR membrane and eight membrane
occupation and recognition nexus (MORN) motifs in the amino
terminus that are thought to interact with the plasma membrane
to stabilize the junctional membrane complexes [11,13].
Knockdown of JP-2 in cultured adult mouse cardiac myocytes
disrupted the T-tubule network [5]. In addition, knockout or
knockdown of JP-2 in the mouse heart led to T-tubule
disorganization, reduced number and altered morphology of
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2+ transients
[11,14]. Currently, it is unknown if the function of JP-2 is
regulated by cell signaling pathways.
Class IA phosphoinositide 3-kinases (PI3Ks) are activated by
various hormones and phosphorylate the membrane lipid phos-
phatidylinositol (4,5)-bisphosphate to produce the second messenger
phosphatidylinositol (3,4,5)-trisphosphate (PIP3) [15]. The enzymes
consist of a catalytic subunit (p110a,p 1 1 0 b, or p110d) associated
with various regulatory subunits collectively referred to as p85. We
previously showed that cardiac-specific ablation of p110a, but not
p110b, resulted in reduced Ca
2+ transients and a mild contractile
defect in adult mice [16]. In this study, we used chronic and acute
models of PI3K deletion to study the effects of ablating p110a,
p110b or both PI3Ks on T-tubule structure. We show that
simultaneous loss of both p110a and p110b throughout develop-
ment or in adulthood disrupts the localization of JP-2 and the
integrity of the T-tubule network, leading to severely compromised
myocyte contraction and fatal heart failure.
Materials and Methods
Materials
CaV1.2 antibody was from Alomone Labs. RyR antibody was
from Affinity Bioreagents. Di-8-ANEPPS, FM 4-64, JP-2 antibody
for immunostaining, goat anti-rabbit antibody conjugated to Alexa
Fluor 488 and goat anti-mouse antibody conjugated to Alexa
Fluor 647 were from Invitrogen. p110a, p110b, and phospho-
specific Akt antibodies were from Cell Signaling Technology.
Pan-p85 antibody was from Millipore; antibodies for Akt and JP-2
(for western blotting) were from Santa Cruz Biotechnology.
Antibody to GAPDH was from Sigma-Aldrich and to caveolin-3
was from BD Transduction Laboratories.
Animals
All animal-related experimental protocols for this study were
approved by the Stony Brook University Institutional Animal Care
and Use Committee under the approval ID #1712. To minimize
animal suffering, mice exhibiting signs of distress such as inability to
keep upright or ruffled fur were euthanized. All genetically
modified mice were in a mixed C57BL/6 and 129 genetic
background. For the chronic model of PI3K ablation, we used a
breeding program between p110a
Flox/WT and p110b
Flox/WT
mice [16] and muscle creatine kinase (MCK)-Cre mice [17].
Offspring from the last breeding step had 16 possible genotypes; in










Flox/Flox;MCK-Cre (called dKO) mice, and
siblings that did not express MCK-Cre served as controls.
Mice with chronic deletion of PI3K were studied at 5 weeks of age
or, where explicitly stated, at 3 weeks of age. For the acute
model of PI3K ablation, p110a
Flox/Flox and p110b
Flox/Flox mice were
bred to transgenic mice expressing a myosin heavy chain
(aMHC)-MerCreMer [18] to generate MerCreMer;p110a
Flox/Flox;
p110b
Flox/Flox double knockout mice (called ind-dKO) and
p110a
Flox/Flox;p110b
Flox/Flox littermates without MerCreMer (called
ind-control) that served as controls. Ind-control and ind-dKO mice
older than 8 weeks of age were injected with tamoxifen (60 mg/kg)
for 5–7 days to induce deletion of the PI3K genes.
Echocardiography
Mice were anesthetized with 1–2% isoflurane and transthoracic
echocardiography was performed as previously described [19].
Left ventricular end-diastolic diameter (LVEDD), left ventricular
end-systolic diameter (LVESD), septal wall thickness and posterior
wall thickness were obtained from 9 cardiac cycles for each
animal. Fractional shortening was calculated as (LVEDD –
LVESD)/LVEDD6100.
T-tubule visualization in vitro and immunofluorescence
microscopy
Cardiac ventricular myocytes were isolated as described earlier
[16]. T-tubules were visualized by incubating living myocytes with
10 mM di-8-ANEPPS in KB solution (5 mM Hepes, 5 mM
MgSO4, 10 mM glucose, 90 mM KCl, 30 mM K2HPO4,
5 mM sodium pyruvate, 1.09 mM NaOH, 0.5 mM EGTA,
20 mM taurine, 5 mM creatine, and 5 mM sodium butyrate,
pH 7.3) for 10 min, followed by a 10 min washout in KB solution.
Di-8-ANEPPS was excited at 488 nm and emission intensity was
measured at 506 nm. Images were acquired using an Olympus
FluoView
TM FV1000 Confocal Microscope with 60X oil lens
(NA=1.42) at room temperature. The acquisition software was
Olympus FluoView
TM FV1000 (Version 1.7). For immunofluo-
rescence microscopy, isolated myocytes were fixed for 10 min in
3.7% formaldehyde, washed thoroughly in phosphate-buffered
saline and permeabilized using 0.2% Triton X-100 with 5% fetal
bovine serum (FBS) for 5 min. After washing in 1% FBS solution,
cells were labeled with primary antibodies overnight at 4uC. The
next day, the cells were washed with 1% FBS solution and then
incubated with Alexa Fluor-labeled secondary antibodies for 1 h.
The cells were rinsed with phosphate-buffered saline and then
mounted in VectaShield (with DAPI) (Vector Laboratories) for
imaging using the Olympus confocal system.
For spatial spectrum analysis, regions of interest without nuclei
were first selected. After background subtraction (to avoid staining
variation and noise), power spectrum was computed by 1D fast
Fourier transform along the longitudinal dimension for each
sample, averaging multiple lines (.10). Normalized power
(calculated as peak power divided by mean power from 0.2 to
0.4 mm
21 for each cell) was averaged and used to compare groups
of cells. Colocalization analysis was done using commercial
software from Imaris (Bitplane Inc.). An unbiased automatic
thresholding method [20] was applied before calculating Pearson’s
coefficients and colocalization percentages.
T-tubule visualization in situ
In situ T-tubule imaging and 2D Fourier analysis were
performed as previously described [5]. T-tubules in isolated hearts
were stained with either FM 4–64 or di-8-ANEPPS during
Langendorff perfusion and imaged by confocal microscopy [5].
Sarcomere length and Ca
2+ transient measurements
Isolated myocytes were electrically stimulated at a frequency of
1 Hz. Contractile properties were assessed using a video-based
sarcomere spacing acquisition system and Fourier-based analysis
software (IonOptix) as previously described [16]. For Ca
2+
transients, myocytes loaded with Fluo-4 AM were excited at
480 nm and emission intensity of Fluo-4 at 535 nm was measured
using an IonOptix photometry system as previously described
[16]. Fluorescence values (F) were normalized to each tracing’s
own minimum fluorescence (FDiastolic) to correct for differences in
Fluo-4 loading. Ca
2+ transient amplitude was calculated as the
difference between peak F/FDiastolic and trough F/FDiastolic.
Insulin treatment
Mice fasted overnight were anesthetized with 100 mg/kg body
weight ketamine and 10 mg/kg body weight xylazine. The inferior
PI3K and T-Tubules
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Human insulin (Novolin R, Novo Nordisk) at 5 U/kg body weight
or an equal volume of saline was injected through the inferior vena
cava. Hearts were collected 5 min later and stored in liquid
nitrogen until use.
Sample preparation and western blotting
Mouse ventricular microsomes were prepared as previously
described [21]. Mouse heart lysates were prepared in RIPA buffer
(50 mM Hepes, pH 7.5, 50 mM NaCl, 50 mM NaF, 10 mM
sodium pyrophosphate, 5 mM EDTA, 1 mM NaVO4, 0.25%
sodium deoxycholate, 1% NP-40, and protease inhibitor cocktail
(Sigma-Aldrich)). Cardiac myocytes were isolated and cell lysates
were prepared as previously described [16]. After immunoblotting,
signals were visualized using an ECL kit (PerkinElmer Life
Sciences), CSPD chemiluminescence kit (Applied Biosystems) or
the Odyssey Infrared Imaging System (LI-COR Biosciences).
Heart histology
Hearts were fixed by perfusion with 10% buffered formalin and
embedded in paraffin. Sections of 10 mm thickness were cut and
stained with hematoxylin and eosin. Images were acquired using
the Olympus IX 70 Fluorescence Microscope with 20X lens or
Olympus (BX41) Microscope with 20X lens. The acquisition
software was Olympus DP Controller for the Olympus IX 70
microscope and CellSens Dimension Imaging for the Olympus
(BX41) microscope.
Real-time RT-PCR
RNA was isolated from hearts of 36–37-day-old mice using Tri
Reagent (Sigma-Aldrich). RNA was converted to cDNA using the
iScript cDNA Synthesis Kit (Bio-Rad) and analyzed by real-time
PCR using the SYBR Green PCR Kit (Qiagen) with a DNA
Engine Opticon (MJ Research). Results were quantified using a
previously described method [22]. Oligonucleotide primers used
were: bMHC—TGCAAAGGCTCCAGGTCTGAGGGC and
GCCAACACCAACCTGTCCAAGTTC. Results were normal-
ized to the expression of 18S RNA.
Statistics
Numerical data are presented as mean 6 SEM or median 6
range. Comparison between groups was evaluated using one-way
analysis of variance (ANOVA) with post-hoc Fisher least significant
difference test. Comparison between two groups was evaluated
using Student’s t-test or Mann-Whitney U test. Results were
considered significant if the P value was ,0.05.
Results
Chronic and acute mouse models of PI3K deletion
To investigate the impact of reduced PI3K activity on the heart,
we created chronic and acute mouse models of p110a and/or
p110b deletion. The chronic model used a breeding program
between p110a
Flox/WT and p110b
Flox/WT mice and animals
carrying a Cre recombinase transgene under the control of the
MCK promoter to generate p110a or p110b knockout mice (a
2/2
and b
2/2, respectively) and double p110a/p110b knockout mice
(dKO). Siblings that did not express Cre served as controls. The
acute model employed a tamoxifen-inducible system previously
used by us to create single PI3K knockout mice [16]. For the
present study, mice homozygous for floxed p110 alleles were bred
to transgenic mice expressing tamoxifen-activated Cre (MerCre-
Mer) under the control of the aMHC promoter to generate double
p110a/p110b knockout mice (ind-dKO) and littermates without
MerCreMer to serve as controls (ind-control). Ind-control and
ind-dKO mice were analyzed after injection with tamoxifen to
induce deletion of the PI3K genes.
Western blotting showed that the targeted p110a and/or p110b
proteins were appropriately down-regulated in the single and
double knockout myocytes in both models (Fig. S1a,c).
Chronic deletion of p110a also appeared to result in decreases
in the p110b and p85 proteins, and a larger decrease in p85 was
seen in dKO myocytes (Fig. S1a). A compensatory decrease in p85
was not consistently seen after acute deletion of p110a and p110b
(Fig. S1c). To evaluate the effect of gene ablation on PI3K
signaling, we examined the phosphorylation of Akt in hearts of
control and knockout animals after injection with insulin. In the
chronic deletion model, insulin-induced Akt phosphorylation was
decreased in a
2/2 hearts and further reduced in dKO hearts, but
there was little or no change in b
2/2 hearts as compared to the
control (Fig. S1b). Interestingly, the total amount of Akt
protein was increased in both dKO and a
2/2 hearts (Fig. S1b).
Insulin-induced Akt phosphorylation was also blunted in the heart
of ind-dKO mice (Fig. S1d).
Cardiac double PI3K knockout mice develop
decompensated heart failure
At birth, all four groups of mice in the chronic PI3K deletion
model behaved normally and were indistinguishable by physical
appearance. However, the dKO mice became less active one or
two days before death and all dKO mice died before 40 days of
age (Fig. 1a). There was no significant difference in the mortality
rate of a
2/2 or b
2/2 mice as compared to control animals
(Fig. 1a). Both left and right ventricles were dilated in the dKO
hearts, whereas no obvious gross changes were observed in the
single PI3K knockout hearts (Fig. S2a). The mean heart weight
(HW) to body weight (BW) ratio was increased by 42% in
dKO mice as compared to controls (10.7660.22 mg/g vs.
7.6160.09 mg/g, n=3 per group, P=0.0003, t-test). Higher
magnification views of hematoxylin and eosin-stained heart
sections did not reveal any obvious differences in organ structure
in the three groups of chronic knockout mice, indicating that the
early mortality of dKO mice was not due to gross defects in
cardiac architecture (Fig. S2b). No localized areas of necrosis or
myocyte damage were detected in the dKO sections (Fig. S2b).
We next used echocardiography to compare the cardiac
function of 5-week-old dKO and control animals. As shown in
Fig. 1b, the dKO mouse exhibited very weak cardiac contractions
even though the electrocardiogram showed a normal sinus
rhythm. Representative echocardiograms of control (Video S1)
and dKO (Video S2) mice are provided in the Supporting
Information. Echocardiographic measurements showed that
average left ventricular end-diastolic diameter, left ventricular
end-systolic diameter and posterior wall thickness were signifi-
cantly altered in dKO hearts (Table 1). In addition, the calculated
average fractional shortening was dramatically decreased by 70%
in dKO hearts as compared to controls (Table 1). Consistent with
the echocardiography findings, we found markedly increased
bMHC mRNA levels, which are often associated with cardiac
dysfunction, in dKO hearts as compared to single knockouts or
controls (Fig. S2c). This severely compromised heart function is
most likely the cause of death in the chronic dKO mice.
Early death due to chronic deletion of p110a and p110b could
be due to developmental abnormalities in cardiac myocytes that
lead to heart failure. We used the acute model of PI3K deletion to
determine whether adult animals are protected from the
deleterious effects of PI3K ablation in the heart. In the absence
of tamoxifen injection, adult ind-control and ind-dKO mice were
PI3K and T-Tubules
PLoS ONE | www.plosone.org 3 September 2011 | Volume 6 | Issue 9 | e24404Figure 1. Ablation of both p110a and p110b in cardiac myocytes causes early death in mice. (a) Kaplan-Meier survival curves for control,
a
2/2, b
2/2 and double knockout (dKO) mice (n=18 for dKO and n=20 for the other groups; *P,0.0001 as compared to control, Mantel-Cox test).
(b) Representative M-mode transthoracic views and electrocardiograms of control and dKO hearts. (c) Kaplan-Meier survival curves for inducible dKO
(ind-dKO) mice and their controls (ind-control) (n=11 per group; *P,0.0001, Mantel-Cox test). (d) Representative M-mode transthoracic views and
electrocardiograms of ind-dKO and ind-control hearts.
doi:10.1371/journal.pone.0024404.g001
Table 1. Echocardiographic measurements.
Control dKO (5 wk) dKO (3 wk) Ind-control Ind-dKO
HR (bpm) 430 6 20 327 6 13 361 6 27 369 6 8
LVEDD (mm) 3.25 6 0.09 *3.96 6 0.15 *2.90 6 0.12 3.85 6 0.18 4.38 6 0.26
LVESD (mm) 1.65 6 0.19 *3.38 6 0.11 1.88 6 0.11 2.28 6 0.24
{3.80 6 0.22
SWT (mm) 0.15 6 0.03 0.13 6 0.03 0.15 6 0.02 0.13 6 0.03
{0.35 6 0.06
PWT (mm) 0.88 6 0.05 *0.72 6 0.07 0.61 6 0.06 0.97 6 0.07 0.96 6 0.08
FS (%) 49.4 6 5.0 *14.7 6 2.7 35.3 6 2.72 40.9 6 4.6
{13.6 6 2.5
LVEDD,leftventricularend-diastolicdiameter;LVESD,leftventricularend-systolicdiameter;SWT,septalwallthickness;PWT,posteriorwall thickness;FS,fractionalshortening;
HR, heart rate in beats per minute (bpm). Values are mean 6 SEM. *Significantly different from the Control group, t-test.
{Significantly different from the Ind-control group,
t-test. n=3 per group.
doi:10.1371/journal.pone.0024404.t001
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mortality was the same in the two groups for up to 1 year.
However, ablation of both PI3Ks upon tamoxifen injection of
ind-dKO mice rapidly led to death (Fig. 1c). Tamoxifen injections
did not cause early mortality in ind-control mice (Fig. 1c). After
tamoxifen treatment for 4–5 days, ind-dKO mice lost weight
(21.160.3 g vs. +1.560.2 g in ind-controls; n=7 per group,
P=8.3610
26, t-test) and moved less. Echocardiography showed
that the cardiac function of ind-dKO mice was also markedly
compromised (Fig. 1d and Table 1). The mean HW/BW ratio was
increased by 59% in ind-dKO mice as compared to ind-controls
(11.7260.33 mg/g vs. 7.8760.13 mg/g, n=3–4 per group,
P=0.0027, t-test). Histological examination of ind-dKO hearts
after tamoxifen treatment showed that both ventricles were
severely dilated, but no localized areas of necrosis or myocyte
damage were observed (Fig. S2d,e). These results indicate that loss
of both p110a and p110b either throughout development or in
adulthood severely compromises the contractile function of the
heart.
Reduced Ca
2+ transients and contractility
To investigate potential mechanisms that could cause heart
failure in the dKO mice, we studied contractility and Ca
2+
handling in ventricular myocytes isolated from 35-day-old mice in
the four groups from the chronic PI3K deletion model. Most of the
control myocytes contracted robustly when electrically stimulated.
However, ,90% of the dKO myocytes did not visibly contract
under the same conditions, and those that did contract did so
poorly. Myocyte contractile function was quantified by measuring
changes in sarcomere length in visibly contracting cells. Contrac-
tility of the dKO myocytes was dramatically reduced by 71% as
compared to control cells (Fig. 2a,b). This decrease was
comparable to the decrease in fractional shortening calculated
from the echocardiography data (Table 1). Contractility was
decreased by 38% in a
2/2 myocytes as compared to controls but
unaffected in b
2/2 myocytes (Fig. 2a,b). We next measured Ca
2+
transients in ventricular myocytes isolated from all four groups of
mice. The dKO myocytes exhibited Ca
2+ transient amplitudes
that were only 25% of control values (Fig. 2c,d). Chronic ablation
of p110a alone caused a more moderate decrease in Ca
2+ transient
amplitude to 48% of the control, whereas ablation of p110b had
no effect on Ca
2+ transients (Fig. 2c,d).
Misalignment of CaV1.2 and RyR
We next asked whether the decrease in Ca
2+ transient
amplitude in dKO myocytes might be due to a change in the
relative positioning of CaV1.2 and RyR in the junctional
membrane complex. Staining of isolated myocytes from control
mice in the chronic PI3K deletion model with antibodies to
CaV1.2 (green) and RyR (red) showed that the two proteins
colocalized (yellow) in highly organized striations (Fig. 3a). The
striated pattern of CaV1.2 and colocalization with RyR were
visibly reduced in the dKO cells (Fig. 3a). Pearson’s coefficient
analysis showed a significant decrease in colocalization of CaV1.2
and RyR in the dKO myocytes (Fig. 3b). In addition, western
blotting of heart microsome preparations showed a reduction in
the level of both proteins in the dKO samples (Fig. S3a). The
degree of spatial periodicity of the two fluorescent signals in
stained cells was quantified using 1D Fourier analysis over multiple
lines along the longitudinal axis. Periodic spacing of about 2 mm
(,0.5 mm
21 dominant spatial frequency with a harmonic at
,1 mm
21) was seen for CaV1.2 and RyR in a representative
control cell (Fig. 3c,d). The dominant frequency for the CaV1.2
signal in the dKO cell was almost lost (Fig. 3c), and that for RyR
was reduced as compared to the control (Fig. 3d). A normalized
output of the Fourier transform revealed significant differences in
the spatial organization of CaV1.2 and RyR between control and
dKO cells (Fig. 3e). Immunostaining of myocytes from the acute
PI3K deletion model also showed reduced colocalization of
CaV1.2 and RyR in ind-dKO vs. ind-control cells (Fig. 3f,g).
Unlike the dKO hearts, a reduction in CaV1.2 protein was not
seen in ind-dKO samples (Fig. S3a). 1D Fourier analysis showed a
significant loss of spatial organization of CaV1.2 and RyR in the
ind-dKO cells (Fig. 3h-j).
Disrupted T-tubule network
Loss of the organized striated pattern for CaV1.2 in dKO and
ind-dKO cells suggested that the T-tubule network might be
affected by the loss of PI3Ks. To visualize T-tubules, we stained
living isolated ventricular myocytes with di-8-ANEPPS, a
lipophilic dye that cannot enter the cell and that stains the cell
surface membrane. Confocal microscopy images of representative
control, a
2/2 and b
2/2 myocytes from the chronic deletion
model show that the T-tubule network exhibited a highly
organized striated pattern (Fig. 4a). In contrast, the T-tubule
network in dKO myocytes was severely disrupted and the striated
arrangement was almost completely lost (Fig. 4a). 1D Fourier
analysis of the di-8-ANEPPS signal showed periodic T-tubule
spacing of about 2 mm in a representative control cell (Fig. 4b),
commensurate with the sarcomere spacing visible in the phase
contrast image (Fig. 4a). There was no discernable dominant
frequency in the Fourier spectrum for the dKO cell (Fig. 4b),
despite its normal sarcomere appearance in the phase contrast
image (Fig. 4a). This result suggests that T-tubule disruption is not
due to damage of dKO cells during the isolation procedure. A
normalized output of the Fourier transform revealed a significant
difference in the spatial organization of T-tubules between the
control and dKO groups, while the single knockouts were not
significantly different from the control (Fig. 4c). Acute deletion of
both p110a and p110b in adult myocytes also led to severe
T-tubule disruption as revealed by di-8-ANEPPS staining of
ind-control and ind-dKO myocytes (Fig. 4d) and 1D Fourier
analysis of the di-8-ANEPPS signals (Fig. 4e,f). We also visualized
the T-tubules in isolated fixed cells by immunostaining for
caveolin-3, which is localized to the plasma membrane [23].
Consistent with the results obtained with di-8-ANEPPS, caveolin-3
staining of dKO and ind-dKO myocytes showed a disordered
pattern as compared to the orderly striations in control and ind-
control myocytes (Fig. S3b). The protein level of caveolin-3 was
not affected by PI3K deletion in either model (Fig. S3a).
To further study T-tubule organization without the myocyte
isolation procedure, we used a confocal imaging technique to
visualize T-tubules in epicardial myocytes on the intact heart and
analyzed the images using 2D Fourier analysis [5]. Control hearts
from 35-day-old mice in the chronic PI3K deletion model showed
a mature T-tubule system in both left and right ventricular
myocytes (Fig. 5a). However, dKO myocytes in both ventricles
displayed severe disruption of the T-tubule network (Fig. 5a,b). In
the acute PI3K knockout model, there was marked T-tubule loss
and disorganization of the striated arrangement of T-tubules in left
ventricular myocytes of ind-dKO hearts (Fig. 5c,d).
To address the question of whether T-tubule disruption is a
primary effect of PI3K deletion or a consequence of heart failure,
we examined younger dKO mice (3 weeks old) in the chronic
knockout model. The T-tubule network in control myocytes was
already well developed at this age (Fig. 6a,b). T-tubules in most of
the dKO myocytes were disrupted (Fig. 6a,b), even though
echocardiography showed that the mice were not in heart failure
PI3K and T-Tubules
PLoS ONE | www.plosone.org 5 September 2011 | Volume 6 | Issue 9 | e24404Figure 2. dKO myocytes have defective contractile function and Ca
2+ transients. (a) Representative contractility tracings measuring %
change in sarcomere length (DSL%) for control, a
2/2, b
2/2 and dKO myocytes. (b) Summary data of contractility in control (n=25), a
2/2 (n=10), b
2/2
(n=14) and dKO (n=22) myocytes. (c) Representative Ca
2+ transient tracings from control, a
2/2, b
2/2 and dKO myocytes. Ca
2+-associated
fluorescence (F) was normalized to each tracing’s own minimum fluorescence (FDiastolic). (d) Summary data of Ca
2+ transient amplitudes from
control (n=13), a
2/2 (n=10), b
2/2 (n=6) and dKO (n=17) myocytes. Values in b and d are mean 6 SEM (*P,0.01 as compared to control,
one-way ANOVA with post-hoc Fisher’s test).
doi:10.1371/journal.pone.0024404.g002
PI3K and T-Tubules
PLoS ONE | www.plosone.org 6 September 2011 | Volume 6 | Issue 9 | e24404Figure 3. CaV1.2/RyR mismatch in dKO myocytes. (a) Confocal microscopy images of myocytes from control and dKO mice colabeled with
antibodies against CaV1.2 (green) and RyR (red). (b) Pearson’s coefficient for colocalization of CaV1.2 and RyR (n=19 cells from $3 hearts per group).
Data shown are mean 6 SEM (*P=8.1610
29, t-test). 1D Fourier analysis of spatial frequency for CaV1.2 (c) and RyR (d) along the longitudinal axis of
representative myocytes (averaged value from .10 lines). (e) The normalized output of 1D Fourier transform analysis from 19–20 cells for each group.
Data shown are mean 6 SEM (*P=0.0001 (CaV1.2) and 0.015 (RyR), t-test). (f) Representative ind-dKO and ind-control myocytes colabeled with
antibodies against CaV1.2 (green) and RyR (red). (g) Pearson’s coefficient for colocalization of CaV1.2 and RyR (n=13–16 cells from $3 hearts per
PI3K and T-Tubules
PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e24404(Fig. 6c and Table 1). However, in contrast to the 5 week-old dKO
myocytes, some of the younger dKO myocytes had normal
T-tubule networks, suggesting that formation of these structures
does not require PI3K (Fig. 6b). These results suggest that PI3K
deletion in the dKO mice causes disruption of the T-tubules,
which then leads to heart failure.
Taken together, these results show that PI3Ks are crucial for
maintaining the T-tubule network in ventricular myocytes. A
defect in T-tubule organization in dKO and ind-dKO myocytes
leads to mislocalization of CaV1.2 in relation to RyR, resulting in
orphaned RyRs [4]. This abnormal structure contributes to the
reduced contractile function of hearts lacking p110a and p110b.
Altered localization of JP-2
JP-2 plays a critical role in the maintenance of T-tubule
organization in cardiac myocytes [5,14]. Western blotting showed
that JP-2 levels were not decreased in dKO or ind-dKO hearts as
compared to their respective controls (Fig. S3a). We therefore used
immunofluorescence microscopy to examine the intracellular
localization of JP-2. JP-2 was distributed in an organized striated
pattern that overlapped with RyR staining in control cells of the
chronic (Fig. 7a–d) and acute (Fig.7e–h) PI3K deletion models.
The striated arrangement of JP-2 and colocalization with RyR
were significantly reduced in dKO (Fig. 7a–d) and ind-dKO
(Fig. 7e–h) myocytes. In addition, dKO myocytes contained
clusters of JP-2, especially in the perinuclear region (Fig. 7a). The
appearance of perinuclear JP-2 was variable in the ind-dKO cells.
These results suggest that p110a and p110b are required for
correct localization of JP-2 so that it can properly appose CaV1.2




Experiments in genetically modified mice have shown that
PI3Ks regulate physiological heart function in a variety of ways.
The class IA PI3K p110a controls heart size and enhances cardiac
contractility by increasing ICa,L in ventricular myocytes [16,24–
26]. PI3K p110b positively regulates autophagy in the heart, but
how that affects cardiac function is not clear [16,27]. The class IB
PI3K catalytic subunit p110c suppresses cardiac contractility and
heart rate by reducing intracellular cAMP levels in the ventricular
myocardium and sinoatrial node, respectively [25,28]. This study
provides the first genetic evidence that p110a and p110b play
pivotal roles in regulating cardiac contractile function by
maintaining the T-tubule network. Ablation of both PI3K isoforms
in the heart led to T-tubule disorganization and loss that appeared
to be due to altered intracellular localization of JP-2. As a
consequence, double knockout ventricular myocytes exhibited
severe Ca
2+ handling abnormalities that resulted in heart failure
and death.
T-tubule loss or reorganization in ventricular myocytes has been
observed in diverse models of heart failure in dogs [7], rats [4], and
mice [29]. Decreased physical coupling between CaV1.2 and RyR
is thought to be a major cause of altered Ca
2+ transients and
reduced contractility seen in these models [4]. Morphological
changes or reduced density of T-tubules have also been seen in
ventricular myocytes from humans with different etiologies of
chronic heart failure [9,10]. Rather than being caused by heart
failure, changes in the T-tubule network may be an early event in
response to cardiac injury. Loss of T-tubules in a pig model of
chronic ischemia occurred before the onset of heart failure [30]. In
addition, one of us [5] showed that T-tubule loss and remodeling
in response to thoracic-aortic banding in rats began before any left
ventricular dysfunction was detected and progressed along with
the development of overt heart failure. Our finding that 3-week-
old dKO mice exhibited T-tubule disarray but not heart failure
supports the idea that the ultrastructural abnormalities are the
primary result of PI3K deletion, and thus the cause of heart
failure. Our results suggest that PI3K signaling is needed to
maintain, but not to form, the normal T-tubule network, and with
progressive disruption of T-tubules the contractile defect becomes
more severe.
The results above suggest that genetic manipulations that
directly affect the stability of T-tubules might be expected to cause
heart failure. Indeed, whole-body deletion of JP-2 resulted in
embryonic lethality [11]. Hearts in JP-2-null embryos showed
weak and irregular heartbeats, and cardiac myocytes had
abnormal Ca
2+ transients and were deficient in 12 nm junctions
between the peripheral plasma membrane and SR. Acute
knockdown of JP-2 in the heart of adult mice also caused impaired
cardiac contractility and mortality due to heart failure [14].
Cardiac myocytes from the adult mice exhibited T-tubule
disorganization, reduction in the number of junctional membrane
complexes, and increased variability in the width of the dyadic
cleft. Similar to the acute JP-2 knockdown model, loss of p110a
and p110b in our acute PI3K double knockout mice disrupted the
structure of an already formed T-tubule network. It is interesting
that deletion of JP-2 led to embryonic lethality [11], whereas our
PI3K dKO mice died several weeks after birth. A recent study of
the postnatal development of cardiac excitation-contraction
coupling in the rat showed that RyR localized to the Z line very
early in development, while JP-2 localization changed from a
peripheral distribution near the plasma membrane in immature
myocytes to the jSR membrane as the T-tubule system matured
[6]. It is possible that PI3K deletion affects T-tubule structure only
after JP-2 and RyR localize to the same compartment.
Interestingly, the striated pattern of RyR was disrupted in both
chronic and acute PI3K dKO myocytes, suggesting that PI3Ks
also regulate membrane organization of the jSR. This could also
be dependent on JP-2 localization since this protein was shown to
coimmunoprecipitate with RyR [14].
A reduction in the amount of JP-2 protein in the left ventricle
was seen in genetic mouse models of hypertrophic or dilated
cardiomyopathy [31]. In addition, JP-2 protein was gradually
down regulated during the progression from compensated
hypertrophy to heart failure in a thoracic-aortic banding rat
model of pathological left ventricular afterload [5]. By contrast, we
saw mislocalization of JP-2 in myocytes from failing dKO and ind-
dKO hearts, but no appreciable loss of JP-2 protein. Interestingly,
JP-2 missense mutants found in human hypertrophic cardiomy-
opathy were reported to mislocalize and perturb Ca
2+ signaling
when expressed in cultured cells of muscle origin [32]. These
results suggest that JP-2 loss or mislocalization can lead to cardiac
pathology.
PI3K-dependent JP-2 localization might be controlled by the
amino-terminal MORN domains [13]. MORN domains in plant
phosphatidylinositol 4-phosphate 5-kinases have been shown to
group). Data shown are mean 6 SEM (*P=0.016, t-test). 1D Fourier analysis of spatial frequency for CaV1.2 (h) and RyR (i) along the longitudinal axis
of representative myocytes (averaged value from .10 lines). (j) The normalized output of 1D Fourier transform analysis from 19 cells for each group.
Data shown are mean 6 SEM (*P=9.8610
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mouse JP-2 containing the MORN repeats was shown to target
proteins to the plasma membrane [11]. These results raise the
possibility that T-tubule membranes from double PI3K knockout
myocytes might contain a reduced amount of PIP3 that prevents
JP-2 from binding and tethering them to the SR. Future studies
Figure 4. T-tubule disruption in dKO myocytes. (a) Confocal microscopy images of myocytes isolated from control, a
2/2, b
2/2 and dKO hearts
and stained with di-8-ANEPPS (green). The small panels on the left are 2x magnified views of the boxed areas. Phase contrast images of the same cells
are displayed on the right. (b) 1D Fourier analysis of spatial frequency along the longitudinal axis of representative di-8-ANEPPS–stained control and
dKO myocytes (averaged value from .10 lines). (c) Normalized power was computed as a measure of T-tubule spatial organization (n=8–20 cells
from $3 hearts per group). Data shown are mean 6 SEM (*P,0.01 as compared to control, one-way ANOVA with post-hoc Fisher’s test). (d) Confocal
microscopy images of myocytes isolated from ind-dKO and ind-control hearts and stained with di-8-ANEPPS. Smaller panels are 2x magnified views of
the boxed areas. Phase contrast images of the same cells are displayed on the right. (e) 1D Fourier analysis of spatial frequency along the longitudinal
axis of representative di-8-ANEPPS–stained cells (averaged value from .10 lines). (f) Normalized power as a measure of T-tubule spatial organization
(n=15–25 cells from $3 hearts per group). Data shown are mean 6 SEM (*P=4.8610
24, t-test).
doi:10.1371/journal.pone.0024404.g004
Figure 5. T-tubule disruption in dKO hearts. (a) In situ T-tubule imaging of myocytes in the left ventricle (LV) and right ventricle (RV) of control
and dKO hearts perfused with FM 4–64. (b) T-tubule organization was analyzed by 2D Fourier analysis. n=10 images from each group. *P=8.3610
210
and 6.8610
25 (t-test) for LV and RV, respectively. (c) In situ T-tubule imaging of myocytes in the LV of ind-dKO and ind-control hearts perfused with
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affects the binding of JP-2. JP-2 has also been shown to
coimmunoprecipitate with caveolin-3 [31], raising the possibility
that protein-protein interactions between JP-2 and PI3Ks might be
important for JP-2 localization.
We previously reported that acute deletion of p110a, but not
p110b, in myocytes of adult mice caused a reduction in
contractility and Ca
2+ transients [16]. Similar results were seen
here in young animals that lacked p110a or p110b during cardiac
development. The severity of the phenotype in dKO and ind-dKO
mice as compared to the single knockouts could be due to a shared
function of the two enzymes in regulating the cellular content of
PIP3. It has been proposed that p110b synthesizes a basal pool of
PIP3 that by itself has little effect on Akt, whereas p110a
synthesizes a much larger pool in response to growth factor
stimulation that is efficiently coupled to Akt phosphorylation [35].
Figure 6. T-tubule abnormality in 3-week-old dKO myocytes. (a) Confocal microscopy images of myocytes isolated from 3-week-old control
and dKO hearts and stained with di-8-ANEPPS. Phase contrast images of the same cells are displayed on the right. (b) Normalized power was
computed for each myocyte as a measure of T-tubule spatial organization (from $3 hearts per group). Data for individual cells are shown and bars
are median, maximum and minimum values (*P,0.01 as compared to control, Mann-Whitney U test). (c) Representative M-mode transthoracic
echocardiographic views of 3-week-old control and dKO hearts.
doi:10.1371/journal.pone.0024404.g006
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PLoS ONE | www.plosone.org 11 September 2011 | Volume 6 | Issue 9 | e24404Figure 7. Disrupted JP-2 distribution in dKO myocytes. (a) Confocal microscopy images of ventricular myocytes from control and dKO mice
colabeled with antibodies against JP-2 (green) and RyR (red). (b) 1D Fourier analysis of spatial frequency for JP-2 along the longitudinal axis of
representative cells (averaged value from .10 lines). (c) Normalized power was calculated as a measure of JP-2 spatial organization (n=15–16 cells
PI3K and T-Tubules
PLoS ONE | www.plosone.org 12 September 2011 | Volume 6 | Issue 9 | e24404Our observation that insulin-induced Akt phosphorylation was
lower in the dKO myocytes than in p110a or p110b single
knockout cells is consistent with loss of both PIP3 pools. Decreased
signaling to Akt in the double knockout myocytes might contribute
to the heart failure phenotype. Alternatively, p110a and p110b
might have different functions in the heart (e.g., PIP3 production
by p110a and promotion of autophagy by p110b) that are both
required for maintaining T-tubule integrity.
In summary, we have demonstrated that the presence of PI3K
p110a and p110b is crucial for maintaining structural integrity of
the T-tubule network and normal cardiac function. These results
may have implications for the use of broad-spectrum PI3K
inhibitors currently being tested in clinical trials for cancer patients
[36]. Our results indicate that patients treated with these drugs,
especially patients with preexisting heart disease or those with
diabetes who may already have reduced PI3K signaling in the
heart, should be closely monitored for cardiac side effects. Partial
inhibition of PI3K by these drugs could exacerbate the underlying
cardiac dysfunction.
Supporting Information
Figure S1 PI3K expression and insulin signaling in PI3K
knockout hearts. (a) Lysates of myocytes isolated from the
indicated groups of mice from the chronic PI3K deletion model
were analyzed by western blotting to detect the p110a and p110b
PI3K catalytic subunits and the p85 regulatory subunit. GAPDH
served as a loading control. (b) Mice were fasted overnight,
anesthetized and injected through the inferior vena cava with
saline or insulin (5 U/kg). Hearts were harvested 5 min later and
lysates were analyzed by western blotting with the indicated
antibodies. (c) Lysates of myocytes isolated from ind-dKO and
ind-control mice from the acute PI3K deletion model were
analyzed by western blotting to detect the indicated proteins.
(d) Mice were injected with insulin as described above and heart
lysates were analyzed by western blotting with the indicated
antibodies.
(TIF)
Figure S2 Characterization of PI3K knockout hearts.
(a) Gross morphology of representative hearts from control, a
2/2,
b
2/2 and dKO mice. Sections were stained with hematoxylin and
eosin (H&E). (b) Representative high power images of H&E-
stained heart sections. (c) Real-time RT-PCR analysis of bMHC
mRNA levels in control, a
2/2, b
2/2 and dKO hearts (n=5 for
control and dKO and n=3 for a
2/2 and b
2/2;* P,0.05 as
compared to control, one-way ANOVA with post-hoc Fisher’s test).
(d) Gross morphology of representative hearts from ind-dKO and
ind-control mice. Sections were stained with H&E. (e) Represen-
tative high power images of H&E-stained heart sections.
(TIF)
Figure S3 Expression of caveolin-3, CaV1.2, RyR and JP-
2. (a) Immunoblots of heart microsomal preparations. Samples in
the left panel were obtained from 2 pairs of control and dKO
hearts. Samples in the right panel were obtained from 2 pairs of
ind-control and ind-dKO hearts. (b) Confocal microscopy images
of isolated ventricular myocytes labeled with antibodies against
caveolin-3.
(TIF)
Video S1 Echocardiogram of a control mouse.
(AVI)
Video S2 Echocardiogram of a dKO mouse.
(AVI)
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